High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study

doi:10.3748/wjg.v29.i23.3645

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2512)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1410

Figures (1-6)

290

Tables (1-2)

275

Sum=2041

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

118

Download

252

Sum=370

Jun 21, 2023 (publication date) through Jun 14, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 21, 2023; 29(23): 3645-3657
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3645

Full Size Figure Download Figure

Figure 3 Nomogram prediction of 1-, 2-and 3-year overall survival rate in patients with gastric cancer. The total points is calculated by adding up the points of each factor. The total points corresponds to the 1-year, 2-year and 3-year survival probability of the patients. OS: Overall survival; TNM: Tumor-node-metastasis.

Citation: Cao XM, Kang WD, Xia TH, Yuan SB, Guo CA, Wang WJ, Liu HB. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study. World J Gastroenterol 2023; 29(23): 3645-3657
URL: https://www.wjgnet.com/1007-9327/full/v29/i23/3645.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i23.3645